J&J | Les Charges D'Exploitation



Operating Expenses Changement Date
AbbVie USD 16.59B 5.96B 2024-12
Abbott USD 8.7B 363M 2025-03
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Boston Scientific USD 3.89B 410M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
CONMED USD 293.44M 42.45M 2024-12
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
Hologic USD 792M 34M 2024-12
Indivior 303M 128M 2024-09
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
J&J USD 8.26B 10.37B 2025-03
Medtronic USD 6.65B 162M 2025-01
Merck USD 11.33B 1.4B 2024-12
Merit Medical Systems USD 318.59M 16.01M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 10.07B 969M 2024-09
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 283.23M 13.17M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12
Zoetis USD 1.59B 71M 2024-12



J&J Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.